# Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke

> **NCT01862978** · PHASE4 · UNKNOWN · sponsor: **University Hospital, Martin** · enrollment: 150 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Heparin
- **DRUG:** Nadroparin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01862978
- **Lead sponsor:** University Hospital, Martin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2015-05
- **Final completion:** 2015-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2013-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01862978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01862978, "Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01862978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*